Update on Safety Issues Related to Antihyperglycemic Therapy.
| Autor: | Carpio, Gandahari Rosa A., Fonseca, Vivian A. |
|---|---|
| Předmět: |
ANEMIA diagnosis
TREATMENT of diabetes HYPOGLYCEMIA LACTIC acidosis PANCREAS GLUCAGON-like peptides CELL physiology DIABETES DRUGS CLINICAL drug trials EDEMA ENZYME inhibitors HYPOGLYCEMIC agents INSULIN INCRETINS MEDICAL care costs SAFETY WEIGHT loss WEIGHT gain SULFONYLUREAS METFORMIN EXENATIDE THIAZOLIDINEDIONES GLIPIZIDE SITAGLIPTIN DIAGNOSIS ANATOMY THERAPEUTICS DISEASE risk factors |
| Zdroj: | Diabetes Spectrum; Spring2014, Vol. 27 Issue 2, p92-100, 9p |
| Abstrakt: | The American Diabetes Association emphasizes the importance of individualized patient care in the management of diabetes. One of the important considerations in choosing an antihyperglycemic agent is its side-effect and safety profile. This article reviews the common and clinically significant side effects of each class of agents, including ways to prevent and overcome their occurrence. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|